Clinical Trials · NCT05027308
A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Aged 4 Months or Older
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Takeda
- Enrollment
- 3
- Start date
- Jan 2022
- Locations
- 6 sites, Japan
- Primary endpoint
- Number of Participants With Treatment-emergent Adverse Events (TEAEs)